NDC11 18657011704
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 18657-0117-04 | 18657-0117 |
| 18657-0117-4 | 18657-0117 |
| 18657-117-04 | 18657-117 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYLENEX Recombinant | HYALURONIDASE | Antares Pharma, Inc. | 3023cc56-ed4b-4e87-b3a1-81b20943f658 | 2024-11-11 | Warnings, Adverse reactions | 18657-117-04 18657-117 18657011704 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.